To better understand the links between circulating insulin and albuminuria in essential hypertension, the plasma insulin response to a 75 gram glucose load and albuminuria were evaluated in 53 glucose-tolerant essential hypertensives and 12 controls. To allow any direct pressure-independent albuminuric effect of insulin to emerge more clearly, those same parameters were also evaluated in 20 glucose-tolerant normotensive patients with stable atherosclerotic peripheral vascular disease, a condition in which hyperinsulinaemia could be anticipated on the basis of previous reports. In response to glucose ingestion, hyperinsulinaemia was evident in both hypertensive and normotensive atherosclerotic patients, while, on average, urine albumin was elevated only in the former. When plasma insulin, systolic and diastolic blood pressure (BP) (by 24-h ambulatory BP monitoring), plasma glucose, triglycerides and
Introduction
The determinants of microalbuminuria (ie, increased urinary albumin excretion (UAE) not detectable by the usual dipstick methods) in essential hypertension are still not completely clarified, though several biological components, including blood pressure (BP) levels, are likely to contribute. 1 Several studies have put evidence a coexistence of raised UAE with hyperinsulinaemia, low high density lipoprotein (HDL) cholesterol and high triglyceride levels, so that hypertensive microalbuminuria has been proposed as a marker of underlying resistance to the peripheral action of the hormone 2 -an interesting concept, implying the primacy of metabolic over haemodynamic factors. 1 A recent hypothesis also postulates a direct action of circulating insulin, which might per se promote albuminuria by increasing endothelial permeability. 2, 3 However, findings of selective hyperinsulinaemia in the presence of increased albuminuria [2] [3] [4] are not
Correspondence: Dr Roberto Pedrinelli, Dipartimento di Cardiologia, Angiologia, Pneumologia, Università di Pisa, Pisa, Italy Received 10 July 1998; revised 9 October 1998; accepted 21 October 1998 body mass index were entered into a multiple regression analysis, only systolic BP appeared to exert an independent effect on urine albumin. Post-glucose load plasma insulin did not differ between hypertensive patients with (n = 14) and without (n = 39) microalbuminuria (albuminuria Ͼ20 g/min). In further analyses, insulin and systolic BP values were divided in quartiles: albuminuria did not differ across insulin quartiles, while it was significantly higher in the top (n = 21) vs the bottom (n = 21) systolic BP quartile. Thus, hyperinsulinaemia and microalbuminuria were unrelated variables in these hypertensive and atherosclerotic patients. Blood pressure, particularly systolic, emerged as a primary predictor of urinary albumin excretion, although the importance of this parameter needs to be proved prospectively.
uniformly consistent in non-diabetic subjects, [5] [6] [7] and even the modulating action of insulin on vascular permeability is somewhat controversial. 8 vs 9 To better understand how circulating insulin levels relate to albuminuria, plasma insulinaemic responses to oral glucose and UAE were measured in a group of carefully screened essential hypertensive and age-matched normal males. To allow any direct albuminuric effect of insulin to emerge more clearly independent of confounding pressormediated influences, 10 we also looked for a clinical condition in which hyperinsulinaemia may coexist with normal BP. For this reason, those same parameters were also evaluated in normotensive patients with atherosclerotic peripheral vascular disease (PVD) in whom hyperinsulinaemia could be anticipated on the basis of previous reports.
11,12

Materials and methods
Subjects
The sample included 85 white males. Requirements for inclusion in the study were fasting blood glucose levels Ͻ6.7 mmol/L (120 mg/dl), preserved glucose tolerance (plasma glucose Ͻ7.8 mmol/L, 140 mg/dl 2 h after 75 gm glucose), HbA 1 c Ͻ6%, serum creatinine Ͻ106.8 mmol/L (1.2 mg/dl), total serum cholesterol Ͻ7.8 mmol/L (300 mg/dl), normal urinary sediment, no urinary tract infection, body mass index (BMI) Ͻ30 kg/m 2 and no evidence or history of congestive heart failure, advanced chronic obstructive pulmonary disease, previous amputation, pain at rest, ischaemic trophic ulcers or gangrene.
The main evaluation group was made up of 53 patients with essential hypertension selected on the basis of repeated determinations of casual BP greater than 140/90 and less than 180/110 as out-patients. Renal ultrasound scan showed normal-sized kidneys and no evidence of cortical scarring or obstructive uropathy. Angiograms, when indicated, had excluded renal artery stenosis, while routine clinical and haematological examinations excluded other secondary forms of hypertension.
The second evaluation group was composed of 20 patients with angiographically documented aortoiliac-femoral atherosclerotic PVD and normal BP levels on several casual measurements confirmed on a 24-h ambulatory basis (Ͻ130/81 mm Hg 13 ) while on no antihypertensive drugs. All had an ankle/brachial index (the ratio between systolic BP measured at the brachial and bilateral posterior tibial artery by Doppler (Stereodop, Promelec, Bourgeais, France)) of less than 0.9 in at least one limb (mean: 0.55 ± 0.1, s.d.) and stable intermittent claudication (pain-free walking distance greater than 200 m on a treadmill). Angiography, performed in all subjects, showed isolated iliac and/or femoral lesions in all patients combined with crural alterations in some. No patient was on lipid-lowering drugs, and all received either ticlopidine or aspirin.
Twelve normal subjects with normal physical examination, routine blood and urinary tests, BP, ECG, abdominal echograms and ankle/brachial index acted as the controls.
Hypertensive patients already on treatment (n = 29) were studied after at least a 2-week drug withdrawal (calcium channel blockers or angiotensin-converting enzyme inhibitors, or both) and experimental evaluations were completed in a 2-week period. The study was carried out in accordance with the Declaration of Helsinki, and the protocol approved by the local Ethical Committee.
Experimental procedures
Anthropometric measurements (height and weight) were made after each participant had removed his shoes and upper garments. Blood samples were obtained between 8.00 and 9.00 am after overnight fasting and 15 min of supine rest.
Ambulatory BP monitoring (ABPM) was performed using an oscillometric monitor (SpaceLabs 90207, SpaceLabs, WA, USA) on a regular work day. Recording began between 8.30 and 9.00 am with readings every 15 min until midnight, and every 30 min from midnight to 8.00 am.
UAE was measured by nephelometry (Behring, Scoppito, Italy, detection limit: 0.1 mg/dl; interassay variation coefficient: 3.5%). To minimise the confounding influence of daily physical activity and facilitate the collection procedure, urine was collected from 8.00 pm to 8.00 am during 3 consecutive days as described in detail elsewhere. 5 Wall thickness and chamber volumes were measured by mono-and bi-dimensional echocardiograms (Hewlett Packard, Andover, MA, USA, Sonos 1000) with 2.5 and 3.5 MHz transducers.
A glucose tolerance test was performed in the morning with a 75 g glucose load. Individuals were asked to fast for 12 to 14 h before the test, and specimens for plasma glucose and insulin were drawn basally and 0.5, 1, 1.5 and 2 h after administration of the glucose load. Plasma glucose was measured by the gluco-oxidase method, and plasma insulin by immunoradiometric assay (Biosource Europe, Nivelles, Belgium, no crossreactivity with human proinsulin); total and HDL cholesterol and triglycerides were assessed by enzymatic colorimetric techniques (Boehringer-Mannheim, Mannheim, Germany). Low density lipoprotein (LDL) cholesterol was calculated as (total cholesterol − [HDLcholesterol + triglyceride/5]).
Data analysis
UAE (g/min) was the average of three consecutive collections (mean variation coefficient: 24%). Microalbuminuria was defined as a value equal to or greater than 20 g/min. ABPM values were the mean of the overall 24-h readings after artifact editing. Area under the curve (AUC) were calculated by the trapezoidal rule. BMI (body weight/squared surface area) and creatinine clearance were derived according to standard formulae. An active smoker was any person consuming tobacco at the moment of recruitment.
Statistics
Log transformation was applied to UAE, triglycerides and insulin as the raw data were not distributed normally. Descriptive statistics were arithmetic means ± standard deviation (s.d.) or medians and ranges for skewed data. Differences among means were tested by one-way ANOVA followed by a Multiple Range Test to evaluate differences between means. The frequency distribution of categorical variables was analysed through 2 statistics. Intraindividual association of variables was tested by Pearson's correlation coefficients. A multiple linear regression analysis was used to test the influence of several predictors on UAE. Statistical significance was set at P Ͻ 0.05. Calculations were performed by using Statgraphics Plus 3.0 (Manugistic, Rockville, MD, USA).
Results
ABPM, cardiac, renal and metabolic variables
Twenty-four hour BP was similar in controls and normotensive PVD patients and elevated in the hypertensives who also showed thicker cardiac walls. Age, proportion of current smokers, end-dias-131 Table 1 Age, smoking habits, 24-h BP, cardiac and renal parameters in controls (n = 12), hypertensive subjects (n = 53) and PVD patients (n = 20). Means ± s.d.
Evaluation variables Controls Hypertensives PVD patients
1.8 ± 0.5 *P Ͻ 0.001 vs controls and ATH.
tolic diameter and renal function did not differ (Table 1) . Fasting and post-load plasma glucose, BMI and triglycerides were elevated in hypertensive subjects. Atherogenic lipids and peak plasma glucose levels were higher in PVD patients than controls, while the difference with hypertensives did not achieve statistical significance (Table 2) .
Insulinaemic responses to oral glucose and albuminuria
Peak (Table 2 ) and integrated ( Figure 1 , left panel) insulinaemic response to oral glucose were abnormal in both hypertensives (P Ͻ 0.01 vs controls) and PVD patient (P Ͻ 0.03 vs controls), while UAE was elevated (P Ͻ 0.001) only in the former (Figure 1 , right panel).
The relationships of albuminuria, insulin and BP
UAE values were unrelated to peak and AUC insulin (r = 0.13, P Ͻ 0.22; r = 0.20, P Ͻ 0.08 respectively), triglycerides (r = 0.12, P Ͻ 0.25), AUC glucose (r = 0.15, P Ͻ 0.15) and BMI (r = 0.04, P Ͻ 0.74) both in the entire group (n = 85) and the hypertensives subset (r = 0.07, P Ͻ 0.6; r = 0.16, P Ͻ 0.24; r = 0.03, P Ͻ 0.8; r = 0.13, P Ͻ 0.34, r = −0.11, P Ͻ 0.41, respectively, n = 53). Significant univariate correlations existed with 24-h BP, more markedly so for systolic values (r = 0.44, P Ͻ 0.00001, n = 85; r = 0.33, P Ͻ 0.016, n = 53, respectively). Multiple linear regression analysis showed no independent effect of post-load insulin, plasma glucose, triglycerides, BMI and diastolic 24-h BP; systolic BP was the only variable independently (P Ͻ 0.00001) predictive of higher UAE values.
Evaluation variables Controls Hypertensives PVD patients
Fourteen subjects were microalbuminuric. Hypertensives with (n = 14) and without (n = 39) microalbuminuria showed no difference in post-load plasma insulin ( Figure 2) ; 24-h BP (142 ± 9/90 ± 9 vs 134 ± 15/85 ± 9, P Ͻ 0.05) was higher in the former group.
UAE did not differ across insulin quartiles ( Figure  3 , left panel, n = 85). It was significantly higher (P Ͻ 0.005) in the top (n = 21) vs the bottom (n = 21) SBP quartile (Figure 3, right panel) .
Discussion
Lack of a relationship between urine albumin and post-load plasma insulin
The emerging data profile of this study performed in carefully selected patients and well standardised experimental conditions, shows quite clearly a dis- sociation between circulating insulin and UAE. This statement is based upon: (1) comparable hyperinsulinaemia upon oral glucose load and divergent behaviour of albuminuria in essential hypertensive subjects and normotensive atherosclerotic patients; (2) no association between albuminuria and glucosestimulated plasma insulin in analyses performed either in the overall sample or in the hypertensive subgroup; (3) comparable insulinaemic responses in normoand microalbuminuric hypertensive patients; (4) comparable albuminuria in the opposite upper and lower post-load insulin quartiles calculated across the entire spectrum of values. The results agree with those obtained by other authors 6 who reported the coexistence of hyperinsulinaemia and normal albuminuria in patients with essential hypertension.
Although our study needs to be interpreted and evaluated in the context of similar clinic-based cross-sectional protocols, [2] [3] [4] [5] [6] comparable conclusions can be drawn even from several large-scale and population-based surveys. In unselected nondiabetic populations, Winocour et al 14 reported an inverse association between albumin/creatinine ratios and insulin levels, Zavaroni et al 15 described a dissociated behaviour of UAE and post-load insulin levels, and Forsblom et al 16 showed lack of significant difference in the glucose-stimulated insulinaemic responses of non-diabetic subjects with and without microalbuminuria. Foyle et al 17 and Agewall et al 18 did find some relationship between elevated UAE and circulating insulin in non-diabetic normo-and hypertensive subjects, but all of the relationships were explained by the confounding effects of age, obesity and glycaemia. Similarly, plasma insulin concentration was unrelated to microalbuminuria after adjustment for hypertension in the non-diabetic individuals recruited in the IRAS study. 19 Glucose-stimulated insulin levels accounted for a very small portion of the total UAE variability in both the IRAS 19 and Kuopio 20 study, as well as in the series of Hodge et al. 21 Finally, in the large cohort of subjects of the Hoorn study, microalbuminuria clustered with diabetes and hypertension, but not with plasma insulin levels. 22 Even in mechanistic experiments, 10-fold acute increments in circulating insulin left albumin excretion unchanged in normal subjects, 9 although acute or chronic hyperinsulinaemia might still behave differently in essential hypertensive subjects, for example by interacting specifically with other factors active on glomerular haemodynamics or permeability (eg, catecholamines, angiotensin II, glucagon, protein diet, sodium balance). Moreover, our negative conclusions cannot exclude that, as both in diabetic 23 and non-diabetic subjects, 16, 19 renal excretion of albumin might be elevated in the presence of a greater degree of insulin resistance, perhaps because of its association with higher BP levels. 10 In fact, an exaggerated insulin response and lower tolerance to glucose load, somewhat increased body weight and hypertriglyceridaemia-in itself suggestive of insulin resistance 24 -characterised our patients. However, insulin sensitivity cannot be predicted easily from circulating levels because of the presence of a decreased insulin metabolic clearance in some essential hypertensives. 25 On the other hand, we aimed specifically at evaluating the relationships between circulating insulin and UAE in this particular project.
The behaviour of metabolic parameters deserves comments in other regards. First, the insulin response to glucose load is affected by a large number of factors, such as degree and distribution of adiposity, sex and physical fitness, smoking, hypertension, treatment with some antihypertensive agents and dyslipidaemia. 24 Therefore, case-control studies such as ours should take into account as many possible confounders as is feasible. In the present study, confounding by gender was excluded by restricting recruitment to males, and body weight-related interactions were minimised by choosing only lean subjects; smoking was distributed uniformly, and BP status carefully screened by 24-h BP monitoring.
Interference from previous antihypertensive treatment also seems unlikely because, firstly, all patients were off-treatment from at least 2 weeks at the moment of sampling, and, secondly, all had previously been treated with angiotensin-converting enzyme inhibitors and calcium-channel blockers; both classes of drugs did not change insulin sensitivity nor circulating insulin in previous reports. [26] [27] [28] A second noteworthy finding is confirmation that PVD patients exhibit hyperinsulinaemia and marginally elevated plasma glucose in response to oral glucose, 12, 13 as well as a high prevalence of triglyceride abnormalities, 29 both suggestive of reduced insulin sensitivity. 24 A new finding is that hyperinsulinaemia cannot be ascribed to hypertension, since the same metabolic abnormality was shared by strictly normotensive and hypertensive subjects; possibly, physical deconditioning due to disease status may be a relevant factor.
30
The relationship between urine albumin and BP Our results obtained in a male cohort further confirm that hypertensive patients with microalbuminuria are characterised by higher BP 1 and highlight the importance of BP as a predictor of UAE, particularly systolic levels which displaced diastolic values in a multiple regression model. We previously reached the same conclusion 31 in a study based upon casual BP measurements biased, perhaps, by the scarce correspondence between office recordings and daily BP monitoring; this limitation was overcome in the present series by using 24-h BP profiles. Systolic BP appeared the main contributor to the development of microalbuminuria even in a recently reported longitudinal observation of treated hypertensive men. 32 Interestingly, microalbuminuria was explained only by systolic BP even in the normoglycaemic, glucose-tolerant males investigated by Woo et al, 33 while fasting insulin contributed independently to urinary albumin:creatinine in the female components of that cohort, 33 suggesting some gender-related interaction to be tested in specifically designed trials. The overriding influence of BP may represent the contribution to hypertensive albuminuria of either purely hydraulic factors 34 or some less obvious mechanisms related to atherosclerotic progression. This latter possibility is not favoured by normal UAE in the presence of clinically manifest vascular disease, but the physiopathological links between microalbuminuria and atherosclerosis are only speculative at this point.
In conclusion, the current data do not support a preferential link between hyperinsulinaemia and microalbuminuria in essential hypertensive patients, while systolic BP levels appear more important as a promoting factor of hypertensive albuminuria. Whether or not systolic BP is a primary predictor of increased UAE needs, however, to be proved by further prospective ad hoc studies.
